Weekly treatment tested to protect hemophilia Patients' joints
NCT ID NCT06752850
Summary
This study is checking if a weekly preventative treatment (efanesoctocog alfa) can improve the health of joints already affected by swelling (synovial hypertrophy) and prevent new joint bleeds in people with moderate or severe hemophilia A. About 37 participants aged 12 and older will receive the weekly treatment for 12 months. Doctors will use ultrasound and MRI scans to closely monitor changes in the participants' joints over the year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sobi Investigational Site
Milan, Italy
-
Sobi Investigational Site
Naples, Italy
-
Sobi Investigational Site
Rozzano, Italy
-
Sobi Investigational Site
Oslo, Norway
-
Sobi Investigational Site
Barcelona, Spain
-
Sobi Investigational Site
Madrid, Spain
-
Sobi Investigational Site
Seville, Spain
-
Sobi Investigational Site
Valencia, Spain
-
Sobi Investigational Site
Gothenburg, Sweden
-
Sobi Investigational Site
Malmo, Sweden
Conditions
Explore the condition pages connected to this study.